
The interdependence of cardiac and renal dysfunction has emerged as a focus of intense interest in heart failure management due to the substantial associated morbidity and mortality. Captured in the clinical entity known as cardiorenal syndrome, recent definitions afford discussion of the acute and longitudinal evaluation and management of these patients. This article discusses potential pathophysiologic mechanisms of cardiorenal syndrome, epidemiology, inpatient and long-term care (including investigational therapies and mechanical fluid removal), and end-of-life and palliative care.
Heart Failure, Cardiotonic Agents, Therapies, Investigational, Palliative Care, Syndrome, Kidney Function Tests, Combined Modality Therapy, Long-Term Care, United States, Renin-Angiotensin System, Risk Factors, Acute Disease, Chronic Disease, Disease Progression, Quality of Life, Cytokines, Humans, Renal Insufficiency, Mortality
Heart Failure, Cardiotonic Agents, Therapies, Investigational, Palliative Care, Syndrome, Kidney Function Tests, Combined Modality Therapy, Long-Term Care, United States, Renin-Angiotensin System, Risk Factors, Acute Disease, Chronic Disease, Disease Progression, Quality of Life, Cytokines, Humans, Renal Insufficiency, Mortality
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 27 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
